3D Plant Design Software Gains Optimal Graphic Capabilities and Even Wider Platform Support.
MOERS, GERMANY - CAD Schroer, developers of the MPDS4 product suite, and Tech Soft 3D (TS3D), the leading provider of core graphics components to the engineering software industry, announced today that MPDS4, a 3D plant design and 2D/3D factory layout system, is now built with the enhanced capabilities of TS3D's 2D/3D engineering development platform, HOOPS.
"MPDS4 is a plant design and project engineering product suite that offers fast, powerful and flexible large-scale layout, design and assembly capabilities from pre-sales concepts to build order. By including HOOPS within the software we were able to provide significant advantages to our customers. Beyond helping to modernize the interface and graphical capabilities of MPDS4, HOOPS' cross-platform nature enables support on all major platforms, including Windows®, Linux® and Unix®," says Michael Schroer, Founding Director of CAD Schroer.
"Like Tech Soft, CAD Schroer is a company 'by engineers for engineers' so our programmers were extremely pleased to see what CAD Schroer was able to do with HOOPS. We're confident that CAD Schroer customers will enjoy the accelerated graphics capabilities that HOOPS brings to MPDS4," says Ron Fritz, CEO of Tech Soft 3D.
Jul 21, 2009
Popular Articles
- Femap® From Siemens PLM Software Now Sold Worldwide Through NEi Software's Reseller Network
- Engineering Simulation Software from ANSYS Used to Help Calibrate Meteorological Instruments on Phoenix Mars Lander
- Sescoi's WorkNC 5-Axis and Auto 5 - a competitive advantage at ALLIO
- Applied Technology Group named Autodesk's Reseller of the Quarter for Excellence in Customer Service
- Autodesk Acquires T-Splines Modeling Technology Assets
- Automotive Tier-One Suppliers Adopt TPM for Faster, Automated Data Translations
- New powerful functionalities for think3’s ThinkDesign 2009.1
- Michael Schley named as 2008 ifma fellow
- Visteon Technology Helps Drivers to Be More Aware of Surroundings
- PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients